Shenzhen Edge Medical

Shenzhen Edge Medical (Ticker: 2675 HK) designs and manufactures robotic systems that assist surgeons performing minimally invasive operations. Founded in 2017, the company offers the Edge Multi-Port and Edge Single-Port Endoscopic Surgical Robots. Both systems are approved by China’s National Medical Products Administration and have received CE marking in the European Union. The company intends to use IPO proceeds for research and development, expanding production capacity, brand promotion, business development, working capital and strategic acquisitions.

The scheduled listing date on Hong Kong Stock Exchange was January 8, 2026. The proposed offering comprises 27,720,000 shares at an indicative price of HKD 43.24 per share. The base offering would represent HKD 1.20 billion, approximately $152.73 million in gross proceeds, excluding any unexercised over-allotment. The indicated IPO market capitalization is HKD 16.77 billion, approximately $2.14 billion.

Morgan Stanley and GF Capital are identified as sponsors.